Zhao HL - Search Results

1

Single-cell RNA Sequencing Analysis Reveals New Immune Disorder Complexities in Hypersplenism.

Zhao HC, Chen CZ, Song HQ, Wang XX, Zhang L, Zhao HL, He JF. Zhao HC, et al. Among authors: zhao hl. Front Immunol. 2022 Jul 5;13:921900. doi: 10.3389/fimmu.2022.921900. eCollection 2022. Front Immunol. 2022. PMID: 35865544 Free PMC article.

2

[Experience of surgical resection of Bismuth-Corlette type I and II hilar cholangiocarcinoma].

Zhao HL, Wei ZG, He JF, Liu JS, Zhao Y, Bao MS. Zhao HL, et al. Among authors: zhao y. Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1145-7. Zhonghua Wai Ke Za Zhi. 2009. PMID: 20021904 Chinese.

3

[Inhibitory effect of NSC348884, a small molecular inhibitor of nucleophosmin, on the growth of hepatocellular carcinoma cell line hepG2].

Zhang J, Zhao HL, He JF, Li HY. Zhang J, et al. Among authors: zhao hl. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Feb;34(1):58-61. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012. PMID: 22737721 Chinese.

4

Downregulation of NPM reverses multidrug resistance in human hepatoma cells via inhibition of P-glycoprotein expression.

Luo F, Li H, Liang J, Jia H, Li X, Xiao H, He X, He J, Tian Y, Zhao H. Luo F, et al. Mol Med Rep. 2017 Apr;15(4):2360-2368. doi: 10.3892/mmr.2017.6246. Epub 2017 Feb 24. Mol Med Rep. 2017. PMID: 28259962

5

γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors.

Tian W, Ma J, Shi R, Ren C, He J, Zhao H. Tian W, et al. Oncol Lett. 2018 Apr;15(4):5433-5442. doi: 10.3892/ol.2018.8026. Epub 2018 Feb 12. Oncol Lett. 2018. PMID: 29552184 Free PMC article.

6

Screening of significant biomarkers related with prognosis of liver cancer by lncRNA-associated ceRNAs analysis.

He J, Zhao H, Deng D, Wang Y, Zhang X, Zhao H, Xu Z. He J, et al. J Cell Physiol. 2020 Mar;235(3):2464-2477. doi: 10.1002/jcp.29151. Epub 2019 Sep 10. J Cell Physiol. 2020. PMID: 31502679

7

The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation.

Chen X, Zhao H, Chen C, Li J, He J, Fu X, Zhao H. Chen X, et al. Oncol Lett. 2020 Jan;19(1):211-220. doi: 10.3892/ol.2019.11121. Epub 2019 Nov 19. Oncol Lett. 2020. PMID: 31897132 Free PMC article.

8

CNOT7 depletion reverses natural killer cell resistance by modulating the tumor immune microenvironment of hepatocellular carcinoma.

Ren C, Ren X, Cao D, Zhao H, Zhai Z, Li H, Li Y, Fu X, He J, Zhao H. Ren C, et al. FEBS Open Bio. 2020 May;10(5):847-860. doi: 10.1002/2211-5463.12836. Epub 2020 Apr 2. FEBS Open Bio. 2020. PMID: 32160402 Free PMC article.

9

The Role of Prefoldin and Its Subunits in Tumors and Their Application Prospects in Nanomedicine.

Mo SJ, Zhao HC, Tian YZ, Zhao HL. Mo SJ, et al. Among authors: zhao hl, zhao hc. Cancer Manag Res. 2020 Sep 23;12:8847-8856. doi: 10.2147/CMAR.S270237. eCollection 2020. Cancer Manag Res. 2020. PMID: 33061580 Free PMC article. Review.

10

Analysis of CNOT Family Gene Expression, Clinicopathological Features, and Prognosis Value in Hepatocellular Carcinoma.

Zhao H, Chen C, Chen X, Zhang D, Li J, Yang C, Ren C, Ren X, Fu X, Li Y, He J, Zhao H. Zhao H, et al. DNA Cell Biol. 2020 Oct 20. doi: 10.1089/dna.2020.5818. Online ahead of print. DNA Cell Biol. 2020. PMID: 33085544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters